Pre-hospital ticagrelor in ST-segment elevation myocardial infarction in the French ATLANTIC population

Publié dans International Journal of Cardiology 2017 Oct 1;244:49-53 Auteurs : Cayla G, Lapostolle F, Ecollan P, Stibbe O, Benezet JF, Henry P, Hammett CJ, Lassen JF, Storey RF, Ten Berg JM, Hamm CW, Van't Hof AW, Montalescot G; ACTION study group. Article disponible en consultant le site Abstract Background and aim : ATLANTIC was…

Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome : the EVERE2ST-HIV study

Publié dans European Heart journal. 2017 Jun; 38(21):1676-1686 Auteurs : Hauguel-Moreau M, Boccara F, Boyd A, Salem JE, Brugier D, Curjol A, Hulot JS, Kerneis M, Galier S, Cohen A, Montalescot G, Collet JP, Silvain J. Article disponible en consultant le site Abstract Background and aim : To explore platelet reactivity on dual antiplatelet therapy…

Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes : A meta-analysis of pivotal trials

Publié dans Platelets 2017 Mar;28(2):174-181 Auteurs : Roule V, Agueznai M, Sabatier R, Blanchart K, Lemaitre A, Ardouin P, Collet JP, Milliez P, Montalescot G, Beygui F. Article disponible en consultant le site Abstract The risk and benefit of GP-IIb/IIIa Inhibition (GPI) in combination with recent antiplatelet regimens in acute coronary syndromes (ACS) remain unassessed.…